Roche, Innovent Sign Billion Dollar Deal for Bispecific Antibodies
By Pavel Ryzhov, Ph.D. Strategic partnerships between companies in the biopharma industry often lead to successful product development and launches. The favorable outcome may be due to leveraging each others’ …
Read More